In this recent project, NNE’s pharma consultants quickly installed sensors and location tracking technology to a mobile CIP (Clean in Place) station.
Read about our 10-day intense design sprint where NNE and our customer co-created a variety of solutions for minimizing manual handling on the customer's filling line.
Read how an expandable data solution was conceived and installed in under 3 weeks for Unibio.
Co-creation, team collaboration and simultaneous project phases are helping this customer add a multi-product line in this urgent capacity expansion project.
Read how we are supporting our customer's new fermentation and recovery multiline which is based on cutting-edge technology and solutions.
Read how NNE's manufacturing intelligence consultants delivered a secure, customizable cloud solution with Amazon Web Services (AWS) for Novo Nordisk D&S device manufacturing site.
With NNE’s support, Lundbeck increased the value of their existing production data with an AWS solution.
Our customer needs an innovation catalogue for a flexible, optimizable pharma manufacturing facility. Find out how NNE's pharma engineering consultants delivered.
Through a series of virtual workshops, our highly experienced lead team secured a robust design combined with the latest technology to ensure success and longevity for the future.
Read about our Conceptual Design (CD) for a district cooling system that has the potential to improve overall performance, improve environmental performance and lower re-investments of cooling units at the customer's facility site.
Read more about NNE's pharma engineering consultancy and owners representative services for Novo Nordisk's large scale greenfield API facility.
Read how NNE's feasibility study served as an investment prospect to help our customer communicate vision and expected capital expenditure to attract investors.
Read how we are helping our customer refurbish a facility to transition from research to early clinical manufacturing of allogenic gene-edited cell therapies.
NNE provided conceptual design, basic design and a detailed design review for Abdi Ibrahim's new multi-purpose, multi-product facility.
Read how NNE's feasibility study gave the customer a basis for decision on an in-house development and production facility for active pharmaceutical ingredients.
NNE provided a site master plan and production concept to help create basis for decision and design concept for the customer.
Read how NNE developed a conceptual design and a implementation strategy for upgrade of a number of existing labs.
Read how NNE helped a US customer expand its filling capacity with minimal shutdown time.
Read how NNE merged seamlessly with Novozymes’ own organization to provide project management for a new innovation campus.
NNE challenged Junshi to choose a modular facility design. Read how this lead to high flexibility in Junshi's large-scale biotech plant.
With focus on multi-party coordination, GMP compliance and fast-track execution, NNE supported Novo Nordisk with design and start-up of launch plant for new oral solid dosage product.
Supported by NNE, Novozymes built a new facility for solid state fermentation of enzymes in India. Read more about the large supply chain consolidation project.
Tackling both contamination and financial risk, NNE supported Roche in the design of a highly sophisticated fill and finish facility for antibody drug conjugates.
When Zhejiang Medicine Co. Ltd. needed to build its first biotech manufacturing plant in China, it chose NNE as its engineering partner to leverage on our experience in biotech facility design, single-use and isolator technology.
Read how NNE's conceptual design accommodates Emergent Biosolution's need for flexibility and rapid changeover in its filling facility.
With a risk-based approach, NNE supported Libbs Farmacêutica with a single-use monoclonal antibody (mAb) capacity expansion – while maintaining full-scale production.
Read how NNE is helping to ensure flexibility in the aseptic filling processes in Novo Nordisk’s new aseptic filling facility.
NNE was strongly involved in establishing Novo Nordisk’s insulin formulation and filling plant in Tianjin. Read about the impressive fill and finish plant.
When UCB built a new biotech manufacturing plant for antibody drugs, we were in charge of project management. Read about this huge biotech project.
Focusing on agile project execution and good manufacturing practice, NNE supported Novo Nordisk in a critical shutdown. Read about the fast-track project.
Roche’s solid dosage manufacturing plant had to accommodate high-potency solid dosage forms. Read how NNE’s OSD facility engineering helped achieve that.
In a joint effort with NNE, LEO Pharma optimized its active pharmaceutical ingredients plant. Read how team work enabled a fast-track API facility upgrade.
Get the full story on how NNE helped Merz Group Services complete a GMP upgrade of its non-sterile dosage form plant without interrupting production.
Novo Nordisk had to expand capacity for a new insulin analogue. Read how our pharma engineering expertise helped us build a biotech plant in record time.
Read about the optimization of one of the world’s largest enzyme fermentation plants – Novozymes’ industrial biotechnology facility in Hongda, China.
NNE designed a cleanroom for cell-based, personalized cancer treatments. Read why the cleanroom had to be able to run without interruption.
We provided biotechnology engineering for Novozymes’ new, advanced enzyme plant for biofuel in Nebraska. Read about our biggest offshoring project ever.
Novo Nordisk needed to boost capacity for active pharmaceutical ingredients. Read how agile planning ensured minimal down-time during the API upgrade.
Novo Nordisk needed to expand its capacity for active pharmaceutical ingredients. Read how NNE helped to bring a new greenfield API facility to life.
We challenged another company’s design for Aguettant's greenfield plant. Read how our alternative solution ensured improved GMP and operability level.
Novo Nordisk has established a new multipurpose biopharm filling facility in Kalundborg. Read how we supported the fill and finish project.
Fresenius Krabi Brazil wanted to modernize its infusion solutions facility. Read how we helped visualize the customer’s future pharma manufacturing.
Beijing Fresenius Pharmaceutical needed to establish a new compliant pharma production facility. Read how NNE helped ensure full GMP compliance.
Read how our lab design helped turn an old building into a cutting-edge laboratory and several research facilities for the University of Copenhagen.
Read how NNE set up a risk- and science-based verification system for UCB Pharma’s GMP-compliant facility for biomanufacturing.
Read how we put our knowledge of biotech and pharma manufacturing to good use in the design and engineering of laboratories at new Aalborg hospital.
Campus Aas contains 35,000 m² laboratories and BSL vivariums based on NNE's design, architectural and HVAC work. Read more about the lab design project.
Read the story about NNE’s long-term commitment in the expansion of Sanofi Pasteur’s GMP manufacturing facility for vaccines in Shenzhen, China.
Samsung Biologics’s QbD pharmaceutical facility features a quality program designed by NNE. Read about the quality and verification principles behind it.
Rentschler Biotechnologie expanded its biotech production capacity. Read how NNE’s qualification effort helped ensure the facility passed GMP inspection.
Read how we applied our fill finish pharma expertise to integrate a new filling facility for small volume parenterals (SVPs) into an existing site.
Read how our pharmaceutical plant design helped PT Widatra Bhakti meet its capacity problems and new authority requirements.
Read how NNE helped obtain regulatory approval for a fish oil-based biotech product and double GMP manufacturing capacity.
NNE helped streamline Pfizer's verification systems. Read how the large ASTM implementation made commissioning and qualification more cost-effective.
Read how NNE’s local biotech pharma know-how came in handy when we helped Novozymes build an industrial biotech plant for cost-effective enzyme production.
Read how we leveraged our biotech expertise to help Novo Nordisk transfer the assembly and packaging of its device, NovoPen®4, from Denmark to China.
NNE provided the biotech facility design for Novo Nordisk’s cGMP facility. Read why it was named facility of the year and praised for its facility design.
NNE helped Novo Nordisk build its first facility based solely on single-use technology. Read how single use resulted in greater flexibility and lower cost.
When we helped Novo Nordisk build a biotech facility it included an advanced automation system. Read about the ambitious pharma automation and IT project.
Read how our GMP training enabled Kyong Dong's own qualification team to qualify the company’s new tablet plant, which is its first GMP-compliant facility.
Read the story about Malaysia’s first cGMP-compliant biotech facility and how NNE helped Inno Biologics implement good manufacturing practice.
Based on NNE’s facility design, HLL Biotech Limited is building a major vaccine R&D and production plant. Read about India’s largest vaccine project ever.
Read how NNE’s multipurpose facility design enabled Hisun to produce sterile and nonsterile dosage forms under cGMP and high containment conditions.
hameln’s sterile plant for liquid pharmaceuticals is designed by NNE. Read why the sterile facility received an ISPE award for operational excellence.
Find out how NNE’s qualification and validation team helped GSK Biologicals’ build a new GMP vaccine plant in time to meet seasonal production demands.
Read about Geistlich Pharma's biomaterials plant, which is based on advanced process technology and in full compliance with global regulatory requirements.
Read how NNE’s elaborate process analysis helped Fresenius Kabi Austria to optimize its manufacturing line for sterile products filled in glass bottles.
Fresenius Hemocare CZ revamped its blood bag facility for assembly, filling, sterilizing and packing. Read how NNE helped ensure ISO and cGMP compliance.
Read how NNE assists CSL Behring in its qualification activities during the annual summer shutdown to make sure that production restarts on time, every time.
Read the story about Boehringer Ingelheim's first biotech facility in Asia, which is based on NNE’s Bio on demand™ concept for flexible faciity design.
Read how we applied our expertise in process technology for cell-therapeutics and GMP compliance when building Bioheart's new personalized medicine plant.
Read how NNE helped Bavarian Nordic transform an existing pharma production building into a qualified vaccine production cGMP facility in just 11 months.
Read how NNE used single-use technology to help FinVector build a BSL2 cell culture production plant for gene-based biopharmaceutical products.
PT Widatra Bhakti built a new large volume parenterals facility based on NNE’s facility design. Read about the fast-track project.